💊 Health Futures #34

Happy Monday 👋

This week's health news highlights advancements in digital health, biotechnology clinical trials, and AI in healthcare. The latest digital health news, Kyriba partnered with Saudi German Health (SGH). Kyriba's solutions will automate key treasury processes, enhance accuracy, and provide real-time visibility into liquidity positions. In Biotechnology, Sanofi's Tolebrutinib missed the primary endpoint in two Phase III trials in which the drug candidate slowed disability progression in patients with MS compared to a placebo. For AI in health this week, Google introduced a significant AI system that potentially detects early signs of disease by analyzing audio signals.  In terms of health funding, Spring Health secured a $100M Series E funding round, increasing its valuation to $3.3B..

💉 Digital Health

🖥️ Kyriba partnered with Saudi German Health (SGH) to provide advanced treasury solutions. SGH will use Kyriba’s platform to automate key treasury processes, enhance accuracy, and improve financial visibility aiming to offer a new standard for treasury management in the healthcare industry.

✨ ST Engineering and Royal Philips partnered to offer complementary digital health solutions. The partnership aimed for bedside support and capacity management combining ST Engineering's operations command center, robotics, and AI-enabled applications with Philips' clinical command center.

🧠 Birmingham and Solihull ICB launched digital social prescribing. This launch helps to meet the growing demand for mental health support. Social prescribing is an approach that connects people's social and emotional needs to their well-being.

🧬 BioTech Clinical Trials

🫀Abbott's heart clip showed partial success in the trial. The MitraClip device for treating failure reduced hospitalization and improved health status in patients but it failed to lower the death rates.

🔬 Bayer's Kerendia reduced the risk of cardio death. The pharmaceutical company revealed from the phase 3 trial that the Kerendia drug reduced the risk of cardiovascular death in patients with certain types of heart failure.

💉 Sanofi's mixed results in Multiple Sclerosis drug trials.  Sanofi has missed the primary goal of drug candidates of two clinical trials to treat relapsing forms of the disease. Still, on the positive side, a less common form of progressive MS (multiple sclerosis) succeeded.

💻 AI in Health

🏥 Neko Health opens in London. The founder of Spotify uses AI body-scanning technology for preventive health purposes that can detect conditions like heart disease and skin cancer.

🤖 Aidoc secured the CE marking of four new AI algorithms. The algorithm strengthens the ability of the aiOS platform for healthcare providers in Europe.

🔊 Google introduced a groundbreaking AI system. The AI model can detect tuberculosis through the sound of coughs and breathing patterns. The algorithm is trained with 300M audio samples including coughs, sniffles, and breathing patterns, and aims to identify diseases like tuberculosis (TB).

💰 Deals of the Week

🍃 Spring Health, a mental health benefits provider, secured a $100M Series E funding round, which has increased the company's valuation to $3.3B.

📱 Samsung Medison, an affiliation of Samsung Electronics, acquired Sonio for $96M following the approval of the French Ministry of the Economy and Finance.

🧫 Circle Pharma, a CA-based clinical-stage company, raised $90M in Series D funding intending to fund the clinical development of CID-078 (cyclin A/B RxL inhibitor).

👩‍⚕️ Doccla, a provider of virtual ward and remote patient monitoring services, raised a funding of $38.6M Series B funding round for expanding in Europe.

💵 Vesta Healthcare secured a $35M venture loan facility from Horizon Technology Finance. Initially, a $25M portion has been funded. The loan is utilized for growth and working capital purposes.

Thank you for reading. Have a great week ahead!
Have some feedback or suggestions? Let us know at hello@holoniq.com